Skip to content

Cannabis: all studies

Page 258 of 288: studies 2,571 to 2,580 of 2,874, newest first. Back to the cannabis overview

Research

Drug Abuse and Cardiac Problem

Medicine Today February 10, 2014 Mohammad Shafiqur Rahman Patwary, Kazi Abdullah Al Mamun 4 citations

Drug abuse has reached epidemic proportions in many countries including Bangladesh and threatens to overwhelm economic, social, and health care systems. In addition to their effects on the central nervous system, many of these agents induce profound changes in the heart and circulation that are responsible for a significant proportion of drug-related morbidity. Drugs that can affect the...

Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.

Psychopharmacology February 2014 Torbjörn U C Järbe, Brian J LeMay, Aneetha Halikhedkar et al.

The "subjective high" from marijuana ingestion is likely due to Δ(9)-tetrahydrocannabinol (THC) activating the central cannabinoid receptor type 1 (CB1R) of the endocannabinoid signaling system. THC is a weak partial agonist according to in vitro assays, yet THC mimics the behavioral effects induced by more efficacious cannabinergics. This distinction may be important for understanding...

Is schizophrenia a dopamine supersensitivity psychotic reaction?

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 3, 2014 Mary V. Seeman, Philip Seeman

Adolf Meyer (1866-1950) did not see schizophrenia as a discrete disorder with a specific etiology but, rather, as a reaction to a wide variety of biopsychosocial factors. He may have been right. Today, we have evidence that gene mutations, brain injury, drug use (cocaine, amphetamine, marijuana, phencyclidine, and steroids), prenatal infection and malnutrition, social isolation and...

DOI: 10.1016/j.pnpbp.2013.10.003 (opens in new tab) Full text (opens in new tab) D1d2 receptor dimer D2d2 receptor dimer Dopamine release Mutation +2

Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms.

Frontiers in Pharmacology 2014 Petra Amchova, Jana Kučerová, Valentina Giugliano et al.

Depression has been associated with drug consumption, including heavy or problematic cannabis use. According to an animal model of depression and substance use disorder comorbidity, we combined the olfactory bulbectomy (OBX) model of depression with intravenous drug self-administration procedure to verify whether depressive-like rats displayed altered voluntary intake of the CB1 receptor...

Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.

Journal of Psychopharmacology January 2014 John Turner, Andrew C. Parrott, Julia Goodwin et al.

The recreational drug MDMA (3,4-methylenedioxymethamphetamine) or 'Ecstasy' is associated with heightened psychiatric distress and feelings of depression. The Drugs and Infancy Study (DAISY) monitored the psychiatric symptom profiles of mothers who used Ecstasy/MDMA while pregnant, and followed them over the first year post-partum. We compared 28 young women whom took MDMA during their...

Seeking the Sacred with Psychoactive Substances

2014 9 citations

Can drugs be used intelligently and responsibly to expand human consciousness and heighten spirituality? This two-volume work presents objective scientific information and personal stories aiming to answer the question. The first of its kind, this intriguing two-volume set objectively reports on and assesses this modern psycho-social movement in world culture: the constructive medical use of...

Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs

Natural Product Reports 2014 Giovanni Appendino, Alberto Minassi, Orazio Taglialatela‐scafati 65 citations

Covering: up to December 2013. Over the past decade, there has been a growing transition in recreational drugs from natural materials (marijuana, hashish, opium), natural products (morphine, cocaine), or their simple derivatives (heroin), to synthetic agents more potent than their natural prototypes, which are sometimes less harmful in the short term, or that combine properties from different...

DOI: 10.1039/c4np00010b (opens in new tab) Mescaline MDMA Recreational drug Internet privacy +8

Magic Mushroom Growing Kits: A new method for infringement of the narcotic laws.

Turkish Journal of Forensic Medicine 2014 Faruk Aşıcıoğlu, Mustafa Okudan, Nilay Derman et al. 1 citation

The use of psychoactive substances of fungal origin for recreational purposes has become an increasing problem in many countries all over the world. These fungis known as magic mushrooms can be grown wildly however their cultural products has been marketing more often. If their wild products are mistakenly collected and eaten by someone, there is not any infringement of law. Whereas marketing...

DOI: 10.5505/adlitip.2014.60566 (opens in new tab) Magic telescope Mushroom poisoning Law Narcotic +2

Salvinorin a and related compounds as therapeutic drugs for psychostimulant-related disorders.

Current Drug Abuse Reviews 2014 Rafael G. Dos Santos, José A. Crippa, J P Machado-De-Sousa et al. 10 citations

Pharmacological treatments are available for alcohol, nicotine, and opioid dependence, and several drugs for cannabis-related disorders are currently under investigation. On the other hand, psychostimulant abuse and dependence lacks pharmacological treatment. Mesolimbic dopaminergic neurons mediate the motivation to use drugs and drug-induced euphoria, and psychostimulants (cocaine,...

DOI: 10.2174/1874473708666150107122741 (opens in new tab) Full text (opens in new tab) Salvinorin a Psychostimulant addiction Addiction treatment Dopamine regulation

Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.

Experimental and Clinical Psychopharmacology December 2013 Carl A Roberts, Stephen H Fairclough, Francis P McGlone et al.

Executive functioning deficits are reported in ecstasy users. However research into mental set switching has been equivocal, with behavioral studies suggesting the function is preserved. The current study sought to address the issue of switching deficits in ecstasy users by combining behavioral performance with electrophysiological correlates (electroencephalography; EEG). Twenty ecstasy...